These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 7304626)

  • 1. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
    Kowalsky RJ; Dalton DR
    Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Stability of stannous ion in stannous pyrophosphate kits.
    Kowalsky RJ; Chilton HM
    J Nucl Med; 1983 Nov; 24(11):1080-1. PubMed ID: 6631529
    [No Abstract]   [Full Text] [Related]  

  • 3. Technetium-99m labeling of polymorphonuclear leukocytes: preparation with two different stannous agents.
    Kelbaek H; Fogh J
    J Nucl Med; 1985 Jan; 26(1):68-71. PubMed ID: 3965654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction.
    Huckell VF; Lyster DM; Morrison RT; Cooper JA
    Clin Nucl Med; 1985 Jul; 10(7):455-62. PubMed ID: 4028596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro technetium-99m red blood cell labeling using commercial stannous pyrophosphate.
    Zimmer AM
    Am J Hosp Pharm; 1977 Mar; 34(3):264-7. PubMed ID: 857670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m radiopharmaceutical preparation by surface adsorbed stannous ions.
    Salehi N; Lichtenstein M; Pojer PM
    J Nucl Med; 1987 Jun; 28(6):1041-6. PubMed ID: 3675734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiochemical purity and stability of Tc-99m-pyrophosphate].
    Vucina J
    Med Pregl; 2000; 53(9-10):502-5. PubMed ID: 11320732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stoichiometric Tc-99m RBC labeling using stable kit solutions of stannous chloride and EDTA: concise communication.
    Mock BH; Wellman HN
    J Nucl Med; 1984 Aug; 25(8):881-6. PubMed ID: 6431061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of source and age of sodium pertechnetate Tc 99m on radiochemical purity of technetium Tc 99m exametazime.
    Millar AM
    Am J Hosp Pharm; 1993 Jan; 50(1):103-6. PubMed ID: 8381258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the labeling of streptokinase with 99mTc for use as a radiopharmaceutical in the detection of deep-vein thrombosis: concise communication.
    Duffy MJ; Duffy GJ
    J Nucl Med; 1977 May; 18(5):483-5. PubMed ID: 16092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decomposition of Tc-99m pyrophosphate by peroxides in pertechnetate used in preparation.
    Der M; Ballinger JR; Bowen BM
    J Nucl Med; 1981 Jul; 22(7):645-6. PubMed ID: 6265608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo distribution of Tc-99m(Sn)pyridoxylideneisoleucine: effects of storage and labeling conditions. Concise communication.
    Kato M
    J Nucl Med; 1979 Nov; 20(11):1189-93. PubMed ID: 536780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deterioration of stannous ion in radiopharmaceutical kits during storage.
    McBride MH; Shaw SM; Kessler WV
    Am J Hosp Pharm; 1979 Oct; 36(10):1370-2. PubMed ID: 507080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo labeling of red blood cells with Tc-99m with stannous pyridoxylideneaminates.
    Kato M
    J Nucl Med; 1979 Oct; 20(10):1071-4. PubMed ID: 536758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An improved (99m)Tc-aprotinin kit formulation: quality control analysis of radiotracer stability and cold kit shelf life.
    Smyth DR; Tsopelas C
    Nucl Med Biol; 2005 Nov; 32(8):885-9. PubMed ID: 16253814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic aspects of the interaction of 99mTc in association with stannous pyrophosphate with damaged red blood cells.
    Billinghurst MW; Waddell TL
    Int J Appl Radiat Isot; 1983 Mar; 34(3):607-12. PubMed ID: 6303965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Sn(II) ion concentration and heparin on technetium-99m red blood cell labeling.
    Rao SA; Knobel J; Collier BD; Isitman AT
    J Nucl Med; 1986 Jul; 27(7):1202-6. PubMed ID: 3014088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of technetium-99m stannous pyrophosphate in contused myocardium.
    Downey J; Chagrasulis R; Fore D; Parmley LF
    J Nucl Med; 1977 Dec; 18(12):1171-5. PubMed ID: 606739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting the labeling efficiency and stability of technetium-99m-labeled glucoheptonate.
    Zbrzeznj DJ; Khan RA
    Am J Hosp Pharm; 1981 Oct; 38(10):1499-502. PubMed ID: 7294045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion.
    Deutsch E; Libson K; Becker CB; Francis MD; Tofe AJ; Ferguson DL; McCreary LD
    J Nucl Med; 1980 Sep; 21(9):859-66. PubMed ID: 6774066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.